Coya Therapeutics, a clinical-stage biotechnology company based in Houston, announced the successful completion of a private placement, securing $26.5 million in gross proceeds. The private placement involved the sale of 4,370,382 shares of common stock at a price of $6.06 per share, adhering to Nasdaq’s at-the-market pricing rules. After deducting expenses, the net proceeds for […]